Left ventricular (LV) failure can be divided into systolic and diastol
ic dysfunction. The former is characterized by a reduced ejection frac
tion and an enlarged LV chamber, the latter by an increased resistance
to filling with increased filling pressures. Systolic dysfunction is
clinically associated with left ventricular failure in the presence of
marked cardiomegaly, while diastolic dysfunction is accompanied by pu
lmonary congestion together with a normal or only slightly enlarged ve
ntricle. Echocardiography is currently the most relevant technique for
non-invasive differentiation of the two forms. Systolic dysfunction i
s easily assessable by estimation of global ejection fraction and regi
onal wall motion. Diastolic dysfunction can be diagnosed indirectly by
means of a normal or nearly normal ejection fraction and changes of t
he mitral filling pattern in the context of LV failure. For an exact d
etermination of diastolic dysfunction LV catheterization is required.
Systolic dysfunction treatment is well defined, consisting of ACE inhi
bitors, followed by diuretics and digitalis. Calcium channel blockers
are usually contraindicated. Diastolic dysfunction therapy is more dep
endent on the underlying disease. Calcium channel blockers, ACE inhibi
tors or beta-blockers are first line drugs in most instances: diuretic
s can be added with increasing symptoms. Digitalis should be avoided,
except in atrial fibrillation, to control heart rate.